Related Experiment Video
Updated: May 1, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Peripartum cardiomyopathy: A puzzle closer to solution
1James D Fett, Investigations of Pregnancy Associated Cardiomyopathy (IPAC), Peripartum Cardiomyopathy Network of North America (PCN), Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, United States.
Peripartum cardiomyopathy (PPCM) is new heart failure in peripartum patients. Research since 2000 highlights advances, but triggers and treatments for this devastating condition remain elusive.
Area of Science:
- Cardiology
- Obstetrics
- Reproductive Medicine
Background:
- Peripartum cardiomyopathy (PPCM) is defined as new-onset heart failure in the peripartum period.
- Diagnosis requires excluding other known causes of heart failure.
- Significant research has emerged since the 2000 NIH PPCM Workshop.
Purpose of the Study:
- To review key advances in understanding PPCM since 2000.
- To identify remaining unanswered questions regarding PPCM etiology and management.
- To summarize current knowledge on PPCM pathogenesis.
Main Methods:
- Literature review of publications on PPCM since 2000.
- Synthesis of findings on disease mechanisms, triggers, and outcomes.
- Analysis of the impact of pregnancy-related hormonal and immune changes.
Main Results:
- Hundreds of publications indicate the severity of PPCM for young mothers.
- Outcomes have improved, but definitive triggers remain unknown.
- Cardiac angiogenic imbalances are implicated in PPCM development.
Conclusions:
- PPCM pathogenesis involves complex interactions between pregnancy, immunity, and hormones.
- Further research is needed to elucidate specific triggers and develop targeted therapies.
- Understanding angiogenic imbalances is crucial for PPCM management.
More Related Videos
10:08Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management